Recently, long noncoding RNA (lncRNA) of FAM111A (known as FAM111A-divergent transcript or FAM111A-DT) have been shown to promote the progression and poor survival rate of hepatocellular carcinoma (HCC) through its modification by N6-methyladenosine (m6A) [37]. Here, FAM111A is linked to hepatocellular carcinoma.